Eastern tradition · Tonic Herbs

Panax Notoginseng (Sanqi) 三七 · 田七

Yunnan's best-evidenced longevity herb — cardiovascular protection, anti-inflammation, and blood-flow support with 200+ registered clinical trials.

25ClinicalTrials.gov matched
41PubMed RCT records
40Meta-analysis records
2+PubMed records
Notoginsenoside R1, Ginsenoside Rg1, Rb1Key active compound

Data definition. Matched records include all indexed medical endpoints for this intervention — not only longevity. Longevity-relevant records are screened separately and cited in the evidence summary below. Counts are matched-record volumes, not de-duplicated trials and not efficacy claims.

Origin & tradition

Sanqi (三七) has been used in Yunnan medicine for over 400 years to stop bleeding, reduce swelling, and tonify the blood. A core ingredient in Yunnan Baiyao.

Why longevity buyers care

Key active: Notoginsenoside R1, Ginsenoside Rg1, Rb1.

Notoginsenosides (R1, Rg1, Rb1) activate AMPK and eNOS signalling in endothelial cells, reduce platelet aggregation, and protect against ischaemia-reperfusion injury. Multiple large RCTs confirm cardiovascular and cerebrovascular endpoints.

Effect summary

Studied health outcomes

Editorial summary — This table is curated by hand from published research consensus, not automatically calculated from our trial database. Grades reflect our interpretation of the literature. Treat as a starting point, not a definitive verdict. See the Evidence panel below for the underlying trial and paper counts sourced directly from ClinicalTrials.gov and PubMed.
Health outcomeEffectMagnitudeGrade
Platelet aggregation / clotting timeDecreasesModerateB
Cardiovascular markers (post-MI)IncreasesModerateB
Inflammation markersDecreasesMinorC
MicrocirculationIncreasesMinorC

Grade: A = robust RCTs · B = several RCTs / meta-analysis · C = limited or mixed RCTs · D = observational or early data

Dosage guidance

How Panax Notoginseng (Sanqi) is typically used

Typical dose
1,000–3,000 mg/day standardized extract
Form
capsule (standardized to notoginsenosides)
Timing
with meals

Also known as Sanqi (三七) or Tian Qi. Traditional hemostatic use in TCM. Do not combine with anticoagulants (warfarin, aspirin) without medical supervision — notoginsenosides affect platelet aggregation.

Informational only — not a prescription or personalised medical advice. Consult a qualified clinician before starting any supplement or medication.

Evidence summary

What the research actually says

76Evidence confidence
Human RCT evidence41 randomized controlled trials · 40 meta-analyses / systematic reviews

Strong human evidence for cardiovascular, cerebrovascular, and anti-inflammatory endpoints

Notoginsenosides (R1, Rg1, Rb1) activate AMPK and eNOS signalling in endothelial cells, reduce platelet aggregation, and protect against ischaemia-reperfusion injury. Multiple large RCTs confirm cardiovascular and cerebrovascular endpoints.

25registered clinical trials reference this intervention
2selected from 2+ PubMed papers (longevity / aging angle)
Key active: Notoginsenoside R1, Ginsenoside Rg1, Rb1 — a multi-compound botanical extract, so activity is not reducible to a single molecule.

According to PubMed and ClinicalTrials.gov: trial counts from ClinicalTrials.gov, peer-reviewed literature from PubMed. Counts auto-refresh weekly; last checked 2026-09-13. They include trials across many endpoints, not only longevity.

Informational only — not medical advice, a treatment claim, or a substitute for a qualified clinician. Evidence strength varies; we show mixed and null results on purpose.

Compare the evidence

Related ingredients

Suppliers

3 suppliers in our directory carry Panax Notoginseng (Sanqi)

Request sourcing help